Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma

Radiotherapy and Oncology

Volumn 124, Issue 3, 2017, Pages 418-426

  Werner, Lauryn R ^a   Kler, Jasdeep S ^a   Gressett, Monica M ^a   Riegert, Maureen ^a   Werner, Lindsey K ^a   Heinze, Clinton M ^a   Kern, Joseph G ^a   Abbariki, Mahyar ^a   Erbe, Amy K ^a   Patel, Ravi B ^a   Sriramaneni, Raghava N ^a   Harari, Paul M ^a   Morris, Zachary S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Immunomodulation; Immunotherapy; Melanoma; Radiation

Indexed keywords

DEATH RECEPTOR; DNA; INDUCIBLE T CELL COSTIMULATOR; INDUCIBLE T CELL COSTIMULATOR LIGAND; STAT1 PROTEIN; TUMOR MARKER; B7 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

A-375 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE RESPONSE; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MELANOMA; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RADIATION RESPONSE; TIME FACTOR; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; EXPERIMENTAL MELANOMA; FEMALE; GENE KNOCKDOWN; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; B7-1 ANTIGEN; B7-H1 ANTIGEN; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOBLOTTING; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 85028823546     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2017.08.016     Document Type: Article

References (32)

1. Stone, H.B., Peters, L.J., Milas, L., Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst 63 (1979), 1229–1235.
2. Budach, W., Taghian, A., Freeman, J., Gioioso, D., Suit, H.D., Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst 85 (1993), 988–993.
3. Demaria, S., Bhardwaj, N., McBride, W.H., Formenti, S.C., Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 63 (2005), 655–666.
4. Wattenberg, M.M., Fahim, A., Ahmed, M.M., Hodge, J.W., Unlocking the combination: potentiation of radiation-induced antitumor responses with immunotherapy. Radiat Res 182 (2014), 126–138.
5. Sharabi, A.B., Nirschl, C.J., Kochel, C.M., et al. Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen. Cancer Immunol Res 3 (2015), 345–355.
6. Twyman-Saint Victor, C., Rech, A.J., Maity, A., et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520 (2015), 373–377.
7. Reits, E.A., Hodge, J.W., Herberts, C.A., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203 (2006), 1259–1271.
8. Sheard, M.A., Vojtesek, B., Janakova, L., Kovarik, J., Zaloudik, J., Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation. Int J Cancer 73 (1997), 757–762.
9. Reap, E.A., Roof, K., Maynor, K., Borrero, M., Booker, J., Cohen, P.L., Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc Natl Acad Sci U S A 94 (1997), 5750–5755.
10. Deng, L., Liang, H., Burnette, B., Weicheslbaum, R.R., Fu, Y.X., Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression. Oncoimmunology, 3, 2014, e28499.
11. Morris, Z.S., Guy, E.I., Francis, D.M., et al. In situ tumor vaccination by combining local radiation and tumor-specific antibody or immunocytokine treatments. Cancer Res 76 (2016), 3929–3941.
12. Young, K.H., Baird, J.R., Savage, T., et al. Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy. PLoS One, 11, 2016, e0157164.
13. Haraguchi, M., Yamashiro, S., Yamamoto, A., et al. Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci USA 91 (1994), 10455–10459.
14. Alderson, K.L., Luangrath, M., Elsenheimer, M.M., et al. Enhancement of the anti-melanoma response of Hu14.18K322A by alphaCD40 + CpG. Cancer Immunol Immunother 62 (2013), 665–675.
15. Li, C., Huang, S., Armstrong, E.A., et al. Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers. Mol Cancer Ther 14 (2015), 2049–2059.
16. Bernstein, M.B., Garnett, C.T., Zhang, H., et al. Radiation-Induced Modulation of Costimulatory and Coinhibitory T-Cell Signaling Molecules on Human Prostate Carcinoma Cells Promotes Productive Antitumor Immune Interactions. Cancer Biother Radiopharm 29 (2014), 153–161, 10.1089/cbr.2013.1578.
17. Werner, L.R., Huang, S., Francis, D.M., et al. Small molecule inhibition of MDM2-p53 interaction augments radiation response in human tumors. Mol Cancer Ther 14 (2015), 1994–2003.
18. Kim, K.H., Yoo, H.Y., Joo, K.M., et al. Time-course analysis of DNA damage response-related genes after in vitro radiation in H460 and H1299 lung cancer lines. Exp Mol Med 43 (2011), 419–426.
19. Burnette, B.C., Liang, H., Lee, Y., et al. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res 71 (2011), 2488–2496.
20. Lugade, A.A., Sorensen, E.W., Gerber, S.A., Moran, J.P., Frelinger, J.G., Lord, E.M., Radiation-induced IFN-g Production within the Tumor Microenvironment Influences Antitumor Immunity. J Immunol 180 (2008), 3132–3139.
21. Deng, L., Liang, H., Xu, M., et al. STING-Dependent Cytosolic DNA sensing promotes radiation-induced type I Interferon-Dependent antitumor immunity in immunogenic tumors. Immunity 41 (2014), 843–852.
22. Wan, S., Pestka, S., Jubin, R.G., Lyu, Y.L., Tsai, Y.C., Liu, L.F., Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS One, 7, 2012, e32542.
23. Gonzalez-Navajas, J.M., Lee, J., David, M., Raz, E., Immunomodulatory functions of type I interferons. Nat Rev Immunol 12 (2012), 125–135.
24. Shin, D.S., Zaretsky, J.M., Escuin-Ordinas, et al. Primary resistance to PD-1 blockade mediated by JAK1/2 mutations. Cancer Discov 7 (2017), 188–201.
25. Zhu, K., Wang, J., Zhu, J., Jiang, J., Shou, J., Chen, X., p53 induces TAP1 and enhances the transport of MHC class I peptides. Oncogene 18 (1999), 7740–7747.
26. Sheikh, M.S., Burns, T.F., Huang, Y., et al. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 58 (1998), 1593–1598.
27. Pensa S, Regis G, Boselli D, et al. STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin? In: Madame Curie Bioscience Database [Internet]. Austin (TX): Landes Bioscience; 2000-2013.
28. Qing, Y., Stark, G.R., Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279 (2004), 41679–41685.
29. Meissl, K., Macho-Maschler, S., Muller, M., Strobl, B., The good and the bad faces of STAT1 in solid tumours. Cytokine 89 (2017), 12–20.
30. Concha-Benavente, F., Srivastava, R.M., Trivedi, S., et al. Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNgamma that Induce PD-L1 Expression in Head and Neck Cancer. Cancer Res 76 (2016), 1031–1043.
31. Filippi, A.R., Fava, P., Badellino, S., Astrua, C., Ricardi, U., Quaglino, P., Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiother Oncol 120 (2016), 1–12.
32. Sage, E.K., Schmid, T.E., Sedelmayr, M., Gehrmann, M., Geinitz, H., Duma, M.N., Combs, S.E., Multhoff, G., Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients. Radiother Oncol 118 (2016), 176–180.